Cargando…

ICER's second update to pricing models of remdesivir for COVID-19

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692418/
https://www.ncbi.nlm.nih.gov/pubmed/33262564
http://dx.doi.org/10.1007/s40274-020-7299-y
_version_ 1783614507006820352
collection PubMed
description
format Online
Article
Text
id pubmed-7692418
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76924182020-11-27 ICER's second update to pricing models of remdesivir for COVID-19 PharmacoEcon Outcomes News News Item Springer International Publishing 2020-11-28 2020 /pmc/articles/PMC7692418/ /pubmed/33262564 http://dx.doi.org/10.1007/s40274-020-7299-y Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
ICER's second update to pricing models of remdesivir for COVID-19
title ICER's second update to pricing models of remdesivir for COVID-19
title_full ICER's second update to pricing models of remdesivir for COVID-19
title_fullStr ICER's second update to pricing models of remdesivir for COVID-19
title_full_unstemmed ICER's second update to pricing models of remdesivir for COVID-19
title_short ICER's second update to pricing models of remdesivir for COVID-19
title_sort icer's second update to pricing models of remdesivir for covid-19
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692418/
https://www.ncbi.nlm.nih.gov/pubmed/33262564
http://dx.doi.org/10.1007/s40274-020-7299-y